LAMIVUDINE 150 mg/1
lamivudine · TABLET, FILM COATED · Major Pharmaceuticals
No Recall History
Plain English
LAMIVUDINE is a tablet, film coated containing lamivudine at 150 mg/1, taken oral. Manufactured by Major Pharmaceuticals.
Key Facts
- Brand Name
- LAMIVUDINE
- Generic Name
- lamivudine
- NDC Code (Product)
0904-6583- Manufacturer
- Major Pharmaceuticals
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA091606
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 12/02/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is LAMIVUDINE used for?
LAMIVUDINE contains lamivudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is LAMIVUDINE a controlled substance?
LAMIVUDINE is not classified as a controlled substance by the DEA.
What is the generic name for LAMIVUDINE?
The generic name for LAMIVUDINE is lamivudine. There are 10 other brand versions of lamivudine.
What is the NDC code for LAMIVUDINE 150 mg/1?
The NDC (National Drug Code) for LAMIVUDINE 150 mg/1 is 0904-6583, listed by Major Pharmaceuticals.
Other LAMIVUDINE Dosages
Other Lamivudine Brands
See all →- LAMIVUDINE AND ZIDOVUDINE150 mg/172865-144
- lamivudine100 mg/131722-001
- Lamivudine300 mg/133342-002
- COMBIVIR150 mg/149702-202
- LAMIVUDINE and ZIDOVUDINE150 mg/131722-506
- Lamivudine and Zidovudine150 mg/131722-739
- Lamivudine100 mg/131722-752
- Lamivudine150 mg/150742-623
- Lamivudine300 mg/165862-026
- Lamivudine150 mg/133342-001
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)